Merck
We Help Cattle Grow

The science behind Revalor®-XH

Proprietary delayed and extended release technology delivers trenbolone acetate and estradiol in a unique way.

RevalorXH

Designed for heifers fed in confinement, Revalor®-XH delivers the combination of trenbolone acetate and estradiol of two-implant programs in a single administration, thanks to its unique, delayed and extended release technology.

Each Revalor®-XH implant consists of 10 small pellets

  • The first four pellets are uncoated, which allows them to go to work immediately after implanting.
     
  • The other six pellets are coated with a patented polymer. The delayed-release pellets take effect 70 days after implanting, providing the performance of a moderate potency terminal implant without the need for reprocessing.

 

Revalor XH
End section - Uncoated (25x)
  Revalor XH
End section - Coated (25x)

Microscopic view of coated and uncoated pellets

  • Revalor®-XH contains trenbolone acetate and estradiol in a 10:1 ratio.

  • Each pellet contains 20 mg of trenbolone acetate and 2 mg of estradiol, for a total dose of 200 mg of trenbolone acetate and 20 mg of estradiol.

REVALOR® is a registered trademark of Intervet International B.V. Used under license.